KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBIT Margin (2016 - 2025)

Globus Medical (GMED) has disclosed EBIT Margin for 15 consecutive years, with 20.49% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 1132.0% year-over-year to 20.49%, compared with a TTM value of 16.33% through Dec 2025, up 974.0%, and an annual FY2025 reading of 16.33%, up 974.0% over the prior year.
  • EBIT Margin was 20.49% for Q4 2025 at Globus Medical, up from 17.86% in the prior quarter.
  • Across five years, EBIT Margin topped out at 25.71% in Q2 2022 and bottomed at 0.11% in Q3 2023.
  • Average EBIT Margin over 5 years is 14.87%, with a median of 18.07% recorded in 2021.
  • The sharpest move saw EBIT Margin soared 3544bps in 2021, then plummeted -2339bps in 2023.
  • Year by year, EBIT Margin stood at 7.28% in 2021, then surged by 170bps to 19.68% in 2022, then plummeted by -92bps to 1.64% in 2023, then skyrocketed by 458bps to 9.17% in 2024, then soared by 123bps to 20.49% in 2025.
  • Business Quant data shows EBIT Margin for GMED at 20.49% in Q4 2025, 17.86% in Q3 2025, and 10.21% in Q2 2025.